BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Horie H, Yoshida H, Matsuura K, Miyazawa M, Wakabayashi K, Nomoto A, Hashizume S. Isolation of vaccine-derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan. J Med Virol 2002;68:445-51. [DOI: 10.1002/jmv.10224] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Chumakov K, Ehrenfeld E, Wimmer E, Agol VI. Vaccination against polio should not be stopped. Nat Rev Microbiol 2007;5:952-8. [PMID: 17965726 DOI: 10.1038/nrmicro1769] [Cited by in Crossref: 60] [Cited by in F6Publishing: 45] [Article Influence: 4.3] [Reference Citation Analysis]
2 Agol VI. Molecular mechanisms of poliovirus variation and evolution. Curr Top Microbiol Immunol 2006;299:211-59. [PMID: 16568901 DOI: 10.1007/3-540-26397-7_8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 34] [Article Influence: 1.1] [Reference Citation Analysis]
3 Romanenkova NI, Guillot S, Rozaeva NR, Crainic R, Bichurina MA, Delpeyroux F. Use of a multiple restriction fragment length polymorphism method for detecting vaccine-derived polioviruses in clinical samples. J Clin Microbiol 2006;44:4077-84. [PMID: 16957032 DOI: 10.1128/JCM.00017-06] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
4 Tebbens RJD, Pallansch MA, Kew OM, Cáceres VM, Jafari H, Cochi SL, Sutter RW, Aylward RB, Thompson KM. Risks of Paralytic Disease Due to Wild or Vaccine‐Derived Poliovirus After Eradication. Risk Analysis 2006;26:1471-505. [DOI: 10.1111/j.1539-6924.2006.00827.x] [Cited by in Crossref: 120] [Cited by in F6Publishing: 105] [Article Influence: 8.0] [Reference Citation Analysis]
5 Pliaka V, Kyriakopoulou Z, Markoulatos P. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis. Expert Rev Vaccines 2012;11:609-28. [PMID: 22827246 DOI: 10.1586/erv.12.28] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 4.8] [Reference Citation Analysis]
6 Duintjer Tebbens RJ, Zimmermann M, Pallansch MA, Thompson KM. Insights from a Systematic Search for Information on Designs, Costs, and Effectiveness of Poliovirus Environmental Surveillance Systems. Food Environ Virol 2017;9:361-82. [PMID: 28687986 DOI: 10.1007/s12560-017-9314-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
7 Vidor E, Plotkin SA. Poliovirus vaccine—inactivated. Vaccines. Elsevier; 2013. pp. 573-97. [DOI: 10.1016/b978-1-4557-0090-5.00034-3] [Cited by in Crossref: 25] [Article Influence: 3.1] [Reference Citation Analysis]
8 McDonald SL, Weldon WC, Wei L, Chen Q, Shaw J, Zhao K, Jorba J, Kew OM, Pallansch MA, Burns CC, Steven Oberste M. Neutralization capacity of highly divergent type 2 vaccine-derived polioviruses from immunodeficient patients. Vaccine 2020;38:3042-9. [PMID: 32089462 DOI: 10.1016/j.vaccine.2020.02.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Chatterjee A, Vidyant S, Dhole TN. Polio eradication in India: progress, but environmental surveillance and vigilance still needed. Vaccine 2013;31:1268-75. [PMID: 23306357 DOI: 10.1016/j.vaccine.2012.12.060] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
10 Iwai M, Takizawa T, Nakayama T, Matsuura K, Yoshida H, Hasegawa S, Obara M, Horimoto E, Kurata T, Horie H. Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan. Scandinavian Journal of Infectious Diseases 2009;40:247-53. [DOI: 10.1080/00365540701596003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
11 Pavlov D, Van Zyl W, Van Heerden J, Grabow W, Ehlers M. Prevalence of vaccine-derived polioviruses in sewage and river water in South Africa. Water Research 2005;39:3309-19. [DOI: 10.1016/j.watres.2005.05.027] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
12 Agol VI. Vaccine-derived polioviruses. Biologicals 2006;34:103-8. [PMID: 16650771 DOI: 10.1016/j.biologicals.2006.02.007] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 3.3] [Reference Citation Analysis]
13 Bouseettine R, Hassou N, Bessi H, Ennaji MM. Waterborne Transmission of Enteric Viruses and Their Impact on Public Health. Emerging and Reemerging Viral Pathogens. Elsevier; 2020. pp. 907-32. [DOI: 10.1016/b978-0-12-819400-3.00040-5] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Combelas N, Holmblat B, Joffret ML, Colbère-Garapin F, Delpeyroux F. Recombination between poliovirus and coxsackie A viruses of species C: a model of viral genetic plasticity and emergence. Viruses 2011;3:1460-84. [PMID: 21994791 DOI: 10.3390/v3081460] [Cited by in Crossref: 80] [Cited by in F6Publishing: 70] [Article Influence: 8.0] [Reference Citation Analysis]
15 Kirkpatrick BD, Alston WK. Current immunizations for travel: . Current Opinion in Infectious Diseases 2003;16:369-74. [DOI: 10.1097/00001432-200310000-00001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
16 Pliaka V, Kyriakopoulou Z, Tsakogiannis D, Ruether IGA, Gartzonika C, Levidiotou-stefanou S, Krikelis A, Markoulatos P. Correlation of mutations and recombination with growth kinetics of poliovirus vaccine strains. Eur J Clin Microbiol Infect Dis 2010;29:1513-23. [DOI: 10.1007/s10096-010-1033-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
17 Plotkin SA, Vidor E. Poliovirus vaccine-inactivated. Vaccines. Elsevier; 2008. pp. 605-29. [DOI: 10.1016/b978-1-4160-3611-1.50029-5] [Cited by in Crossref: 15] [Article Influence: 1.2] [Reference Citation Analysis]
18 Shimizu H, Thorley B, Paladin FJ, Brussen KA, Stambos V, Yuen L, Utama A, Tano Y, Arita M, Yoshida H, Yoneyama T, Benegas A, Roesel S, Pallansch M, Kew O, Miyamura T. Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. J Virol 2004;78:13512-21. [PMID: 15564462 DOI: 10.1128/JVI.78.24.13512-13521.2004] [Cited by in Crossref: 107] [Cited by in F6Publishing: 54] [Article Influence: 6.3] [Reference Citation Analysis]